Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885975 · ClinicalTrials.gov registry record
Personality Profile of Patients With Apical Ballooning Syndrome
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 53
- Enrollment target
NCT01885975: Completed study, sponsored by Mayo Clinic.
NCT01885975 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01885975 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
The investigators' hypothesis is that patients with apical ballooning syndrome (ABS) will manifest a personality profile that differs than that of a population of similar range of ethnic and socioeconomic status.
Primary Outcome
The "NEO PI-3" measures the five major domains of personality, which are: * Neuroticism * Extraversion * Openness * Agreeableness * Conscientiousness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-09 |
What the finished NCT01885975 record still lists
NCT01885975 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01885975 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01885975 about?
NCT01885975 is a clinical study titled "Personality Profile of Patients With Apical Ballooning Syndrome". The investigators' hypothesis is that patients with apical ballooning syndrome (ABS) will manifest a personality profile that differs than that of a population of similar range of ethnic and socioeconomic status.
What is the current status of trial NCT01885975?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2013-07. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01885975?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia